Profile
Mattis F.
Ranthe served as the Chief Medical Officer at Expres2ion Biotech Holding AB from 2022 to 2023.
Prior to this, he obtained a doctorate degree from the University of Copenhagen in 2013.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 19/09/2022 | 10,753 ( 0.02% ) | 2 493 $ | 30/04/2024 |
Former positions of Mattis Ranthe
| Companies | Position | End |
|---|---|---|
| EXPRES2ION BIOTECH HOLDING AB | Chief Tech/Sci/R&D Officer | 31/12/2023 |
Training of Mattis Ranthe
| University of Copenhagen | Doctorate Degree |
Experiences
Positions held
Connections
28
1st degree connections
2
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 1 |
|---|---|
| Expres2ion Biotech Holding AB |
- Stock Market
- Insiders
- Mattis Ranthe
